Results 201 to 210 of about 1,032,826 (402)

Case Report: Immune checkpoint inhibitor-induced myositis without elevated creatine kinase. [PDF]

Front Immunol
Begaj K, Wilhelm R, Lepper A, Kaufhold M, Veeser J, Grabbe S, Stege H.   +6 more
europepmc   +1 more source

Effects of Ca, Mg, and EDTA on creatine kinase activity in cerebrospinal fluid. [PDF]

, 1979
Petter Urdal, J H Strømme
openalex   +1 more source

Resistance Artery Creatine Kinase mRNA and Blood Pressure in Humans

HYPERTENSION, 2014
F. Karamat, I. Oudman, C. Ris-Stalpers, G. Afink, R. Keijser, Joseph F. Clark, G. V. van Montfrans, L. Brewster   +7 more
semanticscholar   +1 more source

What Are the Normal Serum Creatine Kinase Values for Skeletal Muscle? A Worldwide Systematic Review. [PDF]

Eur J Neurol
Aleksovska K, Kyriakides T, Angelini C, Argov Z, Claeys KG, de Visser M, Filosto M, Jovanovic I, Kostera-Pruszczyk A, Molnar MJ, Sacconi S, Schaefer J, Siciliano G, Vilchez JJ, Toscano A, Schoser B.   +15 more
europepmc   +1 more source

Developmental regulation of creatine kinase isoenzymes in myogenic cell cultures from chicken. Biosynthesis of creatine kinase subunits M and B.

, 1979
M. Caravatti, J.-C. Perriard, Hans M. Eppenberger   +2 more
openalex   +1 more source

Creatine kinase isoenzyme MB in myocardial infarction: methods compared. [PDF]

, 1977
John Griffiths, Gabriele Handschuh
openalex   +1 more source

Disease‐Modifying Trials in Treated Parkinson's Disease: “Stable Treated” Does Not Equate with Biological Stability

Movement Disorders, EarlyView.
Abstract Traditionally, clinical trials of putative disease‐modifying therapies in Parkinson's disease have enrolled untreated patients at the earliest clinical stages of their disease. Due to a number of challenges inherent with this approach, there has been a recent move to a different study design, enrolling patients who are already taking “stable ...
M. Maral Mouradian, A. Jon Stoessl, Anthony E. Lang   +2 more
wiley   +1 more source

Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders.

, 1978
Walid G. Yasmineh, G. A. Ibrahim, M Abbasnezhad, E A Awad   +3 more
openalex   +1 more source

Chromatographic and Electrophoretic Separation of Creatine Kinase Isoenzymes Compared [PDF]

, 1975
Gifford Lum, Arthur L. Levy
openalex   +1 more source

Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL

Muscle &Nerve, EarlyView.
A total of 95 ERT‐experienced adults with LOPD were randomized to switch to cipaglucosidase alfa + miglustat or remain on alglucosidase alfa treatment. After 52 weeks, patients remaining on alglucosidase alfa showed worsening or stability for most outcomes, whereas patients who switched to cipaglucosidase alfa + miglustat generally showed stability or ...
Hani Kushlaf, Jordi Díaz‐Manera, Drago Bratkovic, Barry J. Byrne, Kristl G. Claeys, Paula R. Clemens, Mazen M. Dimachkie, Priya S. Kishnani, Pascal Laforêt, Mark Roberts, Benedikt Schoser, Antonio Toscano, Jeff Castelli, Fred Holdbrook, Sheela Sitaraman Das, Mitchell Goldman, Tahseen Mozaffar, on behalf of the PROPEL Study Group   +17 more
wiley   +1 more source